Đang chuẩn bị liên kết để tải về tài liệu:
Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: A network meta-analysis

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Long-term antiviral treatments are associated with a significantly lower hepatocellular carcinoma (HCC) incidence in chronic hepatitis B (CHB) patients by reducing HBV DNA concentrations. |

TÀI LIỆU LIÊN QUAN

The effect of TNF-α - 308 G>A polymorphism alters the risk of hepatocellular carcinoma

Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma: The debate continues – A mini-review

Comparative effectiveness of angiotensinconverting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: A nationwide high-risk cohort study

A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic function

Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma

A gene-based risk score model for predicting recurrence-free survival in patients with hepatocellular carcinoma

Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population

LIVER TUMORS EPIDEMIOLOGY, DIAGNOSIS, PREVENTION AND TREATMENT

Correlation of chitinase 3-like 1 single nucleotide polymorphisms with hepatocellular carcinoma in Taiwan

Knowledge-based analyses reveal new candidate genes associated with risk of hepatitis B virus related hepatocellular carcinoma
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.